Vaccine Temperatures: Keeping it cool for COVID-19.

With more vaccines being approved worldwide, maintaining the shipments integrity throughout the delivery process is the most challenging hurdle for many logistics providers....

Redefining interoperability in the digital age.

the COVID-19 pandemic accelerated this ability making telehealth mainstream for most medical specialties. These shifts and advancements have also stretched the concept of interoperability...

Bridging the Gaps in Complex Patient Journeys by Enriching Data.

Generating insights about patients on specialty therapies through data aggregation and integration can improve patient outcomes. As the number of specialty drugs expands in complex disease areas...

IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data.

IQVIA announces its strategic collaboration with HealthCore, Inc., a leading real world research organization in the United States, to advance RWE...

Takeda to Manufacture and Provide 150 Million Doses of Novavax COVID-19 Vaccine Candidate to the Govt of Japan.

Takeda Pharmaceutical announced that the Government of Japan's Ministry of Health, Labour and Welfare will purchase 150 million doses of Novavax...

EnGeneIC develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and stimulates a broad anti-viral response.

EnGeneIC has developed a globally unique nanocellular technology that in pre-clinical animal studies has been shown to stimulate anti-COVID-19...

IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud.

IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery.